Skeletal muscle atrophy: From mechanisms to treatments

L Yin, N Li, W Jia, N Wang, M Liang, X Yang… - Pharmacological …, 2021 - Elsevier
Skeletal muscle is a crucial tissue for movement, gestural assistance, metabolic
homeostasis, and thermogenesis. It makes up approximately 40% of the total body weight …

Calpains for dummies: What you need to know about the calpain family

S Spinozzi, S Albini, H Best, I Richard - Biochimica et Biophysica Acta (BBA …, 2021 - Elsevier
This review was written in memory of our late friend, Dr. Hiroyuki Sorimachi, who, following
the steps of his mentor Koichi Suzuki, a pioneer in calpain research, has made tremendous …

Phase 1 study of AAV9. LAMP2B gene therapy in Danon disease

B Greenberg, M Taylor, E Adler, S Colan… - … England Journal of …, 2024 - Mass Medical Soc
Background Danon disease is a rare, X-linked, monogenic cardiomyopathy caused by
mutations in the lysosomal-associated membrane 2 gene (LAMP2), which encodes the …

[HTML][HTML] Muscle-specific promoters for gene therapy

VV Skopenkova, TV Egorova, MV Bardina - Acta Naturae, 2021 - ncbi.nlm.nih.gov
Many genetic diseases that are responsible for muscular disorders have been described to
date. Gene replacement therapy is a state-of-the-art strategy used to treat such diseases. In …

Mechanobiology assays with applications in cardiomyocyte biology and cardiotoxicity

CA Blair, BL Pruitt - Advanced healthcare materials, 2020 - Wiley Online Library
Cardiomyocytes are the motor units that drive the contraction and relaxation of the heart.
Traditionally, testing of drugs for cardiotoxic effects has relied on primary cardiomyocytes …

Single-molecule force spectroscopy on the N2A element of titin: effects of phosphorylation and CARP

T Lanzicher, T Zhou, C Saripalli… - Frontiers in …, 2020 - frontiersin.org
Titin is a large filamentous protein that forms a sarcomeric myofilament with a molecular
spring region that develops force in stretched sarcomeres. The molecular spring has a …

Application of droplet digital PCR technology in muscular dystrophies research

I Lambrescu, A Popa, E Manole, LC Ceafalan… - International Journal of …, 2022 - mdpi.com
Although they are considered rare disorders, muscular dystrophies have a strong impact on
people's health. Increased disease severity with age, frequently accompanied by the loss of …

Systemic AAV9. BVES delivery ameliorates muscular dystrophy in a mouse model of LGMDR25

H Li, P Wang, E Hsu, KM Pinckard, KI Stanford, R Han - Molecular Therapy, 2023 - cell.com
Limb-girdle muscular dystrophy type R25 (LGMDR25) is caused by recessive mutations in
BVES encoding a cAMP-binding protein, characterized by progressive muscular dystrophy …

Muscular dystrophy: Experimental animal models and therapeutic approaches

G Gaina, A Popa - Experimental and Therapeutic …, 2021 - spandidos-publications.com
The muscular dystrophies are a heterogeneous group of genetically inherited diseases
characterized by muscle weakness and progressive wasting, which can cause premature …

Systemic delivery of AAVrh74. tMCK. hCAPN3 rescues the phenotype in a mouse model for LGMD2A/R1

Z Sahenk, B Ozes, D Murrey, M Myers, K Moss… - … Therapy-Methods & …, 2021 - cell.com
Limb girdle muscular dystrophy (LGMD) 2A/R1, caused by mutations in the CAPN3 gene
and CAPN3 loss of function, is known to play a role in disease pathogenicity. In this study …